Company profilePharmaceutical#129 of 1,318 in Pakistan✓ No DRAP alerts

POLYFINE CHEMPHARMA (PVT) LTD.

Pharmaceutical company · 134 brands · 143 molecules

Ranked #107 of 311 companies in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord)

134 registered products 56 pharmaceutical brands 143 distinct molecules 0 DRAP alerts

Company overview

134
registered products
56
pharmaceutical brands
143
distinct molecules
12
therapeutic classes
0
DRAP alerts

POLYFINE CHEMPHARMA (PVT) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 134 product registrations across 143 distinct molecules. It is the 129th largest registrant in Pakistan by product count, and ranks 107th of 311 in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord). Its portfolio is concentrated in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) and Antiemetics & Antinauseants. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by POLYFINE

2 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Blood Glucose Lowering Drugs, Excluding Insulin 1
Antiemetics & Antinauseants 1

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

2
ceilings with an approval date
1
not revised in 2+ years
2024
oldest approval year
20241
20261
Longest without revision

Top molecules by brand count

Thiamine8 brands
Pyridoxine7 brands
Riboflavin6 brands
Paracetamol6 brands
Nicotinamide5 brands
Diclofenac5 brands
Simethicone4 brands

Therapeutic classes

Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 4Antiemetics & Antinauseants · 4Antiinflammatory Agents And Antiinfectives In Combination · 2Other Nervous System Drugs · 2Other Calcium Supplements · 2Beta-Lactam Antibacterials, Penicillins · 2Nasal Preparations · 1Other Urological · 1Vitamin B1, & Combinations Of B1, B6, B12 · 1Ace Inhibitor · 1Lipid Modifying Agents · 1Drugs For Constipation · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official4 products · Rs 85.12 – Rs 1,245.45
Median across source: Rs 489.37

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Wilshire Laboratories (Private) Limited holds 132 molecules not in this portfolio
AcyclovirAcyclovir SodiumAlfacalcidolAmlodipineAmoxicillinAmoxycillin
ZAFA PHARMACEUTICAL LABORATORIES (PVT) LTD. holds 156 molecules not in this portfolio
AlbuterolAmikacinAminophyllineAmlodipineAmlodipine BaseAmmonium Chloride
Albro Pharmaceuticals holds 21 molecules not in this portfolio
AdapaleneAdapleneBetamethasoneClindamycinClioquinolDesloratadine

Get the full profile for POLYFINE

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.